Healthcare & Life Sciences

Monte Rosa Therapeutics

Monte Rosa Therapeutics is a startup based in the United States, most recent round Series-c-plus, 3 tracked investors.

Activeseries-c-plus
series-c-plus
Stage
2018
Founded
3
Investors

About Monte Rosa Therapeutics

Based in the United States, Monte Rosa Therapeutics is a startup founded in 2018. Its most recent tracked round is Series-c-plus. Brouky records 3 investors associated with the company.

Monte Rosa Therapeutics is a clinical-stage biotech company developing molecular glue degraders that use AI, proteomics, structural biology, and chemistry to target proteins for degradation in oncology and immunology diseases.

Explore Monte Rosa Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States